Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.7M Buy
273,716
+51,058
+23% +$1.19M ﹤0.01% 1619
2026
Q1
$4.91M Buy
222,658
+100,448
+82% +$2.51M ﹤0.01% 1833
2025
Q4
$1.19M Buy
122,210
+38,842
+47% +$271K ﹤0.01% 3308
2025
Q3
$333K Sell
83,368
-6,692
-7% -$27.6K ﹤0.01% 4038
2025
Q2
$270K Buy
90,060
+63,616
+241% +$300K ﹤0.01% 4099
2025
Q1
$162K Buy
26,444
+1,863
+8% +$10.8K ﹤0.01% 4158
2024
Q4
$193K Buy
24,581
+6,221
+34% +$62.4K ﹤0.01% 4329
2024
Q3
$196K Buy
+18,360
New +$223K ﹤0.01% 4311

Other funds holding ALMS

Barclays's ALMS Position: Q2 2026 in Review

Barclays increased its Alumis Inc (ALMS) stake by 23% in Q2 2026, buying an estimated $1.19M and bringing the position to 273,716 shares worth $7.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Barclays first reported a position in ALMS in Q3 2024 and has held it in 8 quarters since. 198 funds tracked by Wall St. Rank hold ALMS as of Q2 2026.

  • Barclays held 273,716 shares of Alumis Inc worth $7.7M as of Q2 2026.
  • Barclays bought 51,058 Alumis Inc shares in Q2 2026, an estimated $1.19M.
  • Alumis Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1619 holding.
  • Barclays first reported a position in Alumis Inc in Q3 2024 and has held it in 8 quarters since.
  • 198 funds tracked by Wall St. Rank held Alumis Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.